Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Nancy Davidson
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Anatomy
Physiology
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
16
Armstrong, Deborah
14
Casero, Robert
13
Wolff, Antonio
12
Perez, Edith
10
Kensler, Thomas
10
Baylin, Stephen
9
Ferguson, AT
9
Fetting, John
9
Herman, James
9
Muss, Hyman
8
Nass, Sharyl
8
Lapidus, RG
8
McCloskey, Diane
8
Sparano, Joseph
8
Hahm, Hillary
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Nancy Davidson (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Zhou Qun; Shaw Patrick G; Davidson Nancy E
Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells.
Breast cancer research and treatment 2009;117(2):443-51.
-
2009: Chivukula Mamatha; Brufsky Adam; Davidson Nancy E
Small beginnings: do they matter? The importance of lymphovascular invasion in early breast cancer.
Journal of the National Cancer Institute 2009;101(10):698-9.
-
2009: Madar Igal; Huang Yi; Ravert Hayden; Dalrymple Susan L; Davidson Nancy E; Isaacs John T; Dannals Robert F; Frost J James
Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphonium.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(5):774-80.
-
2009: Carraway Hetty E; Wang Shelun; Blackford Amanda; Guo Mingzho; Powers Penny; Jeter Stacie; Davidson Nancy E; Argani Pedram; Terrell Kyle; Herman James G; Lange Julie R
Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.
Breast cancer research and treatment 2009;114(2):315-25.
-
2009: Higgins Michaela J; Davidson Nancy E
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?
Current oncology reports 2009;11(1):45-50.
-
2009: Emens Leisha A; Davidson Nancy E
Postoperative endocrine therapy for invasive breast cancer.
Cancer treatment and research 2009;151():139-61.
-
2008: Fall-Dickson Jane M; Mock Victoria; Berk Ronald A; Grimm Patricia M; Davidson Nancy; Gaston-Johansson Fannie
Stomatitis-related pain in women with breast cancer undergoing autologous hematopoietic stem cell transplant.
Cancer nursing 2008;31(6):452-61.
-
2008: Arteaga Carlos L; O'Neill Anne; Moulder Stacy L; Pins Michael; Sparano Joseph A; Sledge George W; Davidson Nancy E
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6277-83.
-
2008: Schneider Bryan P; Wang Molin; Radovich Milan; Sledge George W; Badve Sunil; Thor Ann; Flockhart David A; Hancock Bradley; Davidson Nancy; Gralow Julie; Dickler Maura; Perez Edith A; Cobleigh Melody; Shenkier Tamara; Edgerton Susan; Miller Kathy D;
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4672-8.
-
2008: Goldstein Lori J; Gray Robert; Badve Sunil; Childs Barrett H; Yoshizawa Carl; Rowley Steve; Shak Steven; Baehner Frederick L; Ravdin Peter M; Davidson Nancy E; Sledge George W; Perez Edith A; Shulman Lawrence N; Martino Silvana; Sparano Joseph A
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4063-71.
-
2008: Goldstein Lori J; O'Neill Anne; Sparano Joseph A; Perez Edith A; Shulman Lawrence N; Martino Silvana; Davidson Nancy E
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4092-9.
-
2008: Davidson Nancy E
Tracking 35 years of progress against breast cancer.
Oncology (Williston Park, N.Y.) 2008;22(6):593-5.
-
2008: Zhou Qun; Agoston Agoston T; Atadja Peter; Nelson William G; Davidson Nancy E
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells.
Molecular cancer research : MCR 2008;6(5):873-83.
-
2008: Badve Sunil S; Baehner Frederick L; Gray Robert P; Childs Barrett H; Maddala Tara; Liu Mei-Lan; Rowley Steve C; Shak Steven; Perez Edith A; Shulman Lawrence J; Martino Silvana; Davidson Nancy E; Sledge George W; Goldstein Lori J; Sparano Joseph A
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2473-81.
-
2008: Ingle J N; Tu D; Pater J L; Muss H B; Martino S; Robert N J; Piccart M J; Castiglione M; Shepherd L E; Pritchard K I; Livingston R B; Davidson N E; Norton L; Perez E A; Abrams J S; Cameron D A; Palmer M J; Goss P E
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):877-82.
-
2008: Sparano Joseph A; Wang Molin; Martino Silvana; Jones Vicky; Perez Edith A; Saphner Tom; Wolff Antonio C; Sledge George W; Wood William C; Davidson Nancy E
Weekly paclitaxel in the adjuvant treatment of breast cancer.
The New England journal of medicine 2008;358(16):1663-71.
-
2008: Wu Julie M; Fackler Mary Jo; Halushka Marc K; Molavi Diana W; Taylor M Evangeline; Teo Wei Wen; Griffin Constance; Fetting John; Davidson Nancy E; De Marzo Angelo M; Hicks Jessica L; Chitale Dhananjay; Ladanyi Marc; Sukumar Saraswati; Argani Pedram
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):1938-46.
-
2008: Davidson Nancy E
Martin D. Abeloff, MD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1573-4.
-
2008: Goss Paul E; Ingle James N; Pater Joseph L; Martino Silvana; Robert Nicholas J; Muss Hyman B; Piccart Martine J; Castiglione Monica; Shepherd Lois E; Pritchard Kathleen I; Livingston Robert B; Davidson Nancy E; Norton Larry; Perez Edith A; Abrams Jeffrey S; Cameron David A; Palmer Michael J; Tu Dongsheng
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1948-55.
-
2008: Perez Edith A; Suman Vera J; Davidson Nancy E; Sledge George W; Kaufman Peter A; Hudis Clifford A; Martino Silvana; Gralow Julie R; Dakhil Shaker R; Ingle James N; Winer Eric P; Gelmon Karen A; Gersh Bernard J; Jaffe Allan S; Rodeheffer Richard J
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1231-8.
-
2008: Gralow Julie; Ozols Robert F; Bajorin Dean F; Cheson Bruce D; Sandler Howard M; Winer Eric P; Bonner James; Demetri George D; Curran Walter; Ganz Patricia A; Kramer Barnett S; Kris Mark G; Markman Maurie; Mayer Robert J; Raghavan Derek; Ramsey Scott; Reaman Gregory H; Sawaya Raymond; Schuchter Lynn M; Sweetenham John W; Vahdat Linda T; Davidson Nancy E; Schilsky Richard L; Lichter Allen S;
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):313-25.
-
2008: Bao Ting; Davidson Nancy E
Gene expression profiling of breast cancer.
Advances in surgery 2008;42():249-60.
-
2007: Miller Kathy; Wang Molin; Gralow Julie; Dickler Maura; Cobleigh Melody; Perez Edith A; Shenkier Tamara; Cella David; Davidson Nancy E
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
The New England journal of medicine 2007;357(26):2666-76.
-
2007: Stearns Vered; Zhou Qun; Davidson Nancy E
Epigenetic regulation as a new target for breast cancer therapy.
Cancer investigation 2007;25(8):659-65.
-
2007: Park Ben Ho; Davidson Nancy E
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?
Cancer cell 2007;12(4):297-9.
-
2007: Briest Susanne; Davidson Nancy E
Aromatase inhibitors for breast cancer.
Reviews in endocrine & metabolic disorders 2007;8(3):215-28.
-
2007: Cornblatt Brian S; Ye Lingxiang; Dinkova-Kostova Albena T; Erb Melanie; Fahey Jed W; Singh Navin K; Chen Min-Shue A; Stierer Tracey; Garrett-Mayer Elizabeth; Argani Pedram; Davidson Nancy E; Talalay Paul; Kensler Thomas W; Visvanathan Kala
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast.
Carcinogenesis 2007;28(7):1485-90.
-
2007: Sui Meihua; Huang Yi; Park Ben Ho; Davidson Nancy E; Fan Weimin
Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
Cancer research 2007;67(11):5337-44.
-
2007: Davidson Nancy E
The maturation of medical oncology.
The lancet oncology 2007;8(6):457-8.
-
2007: Visvanathan K; Santor D; Ali S Z; Brewster A; Arnold A; Armstrong D K; Davidson N E; Helzlsouer K J
The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):950-5.
-
2007: Goss Paul E; Ingle James N; Martino Silvana; Robert Nicholas J; Muss Hyman B; Piccart Martine J; Castiglione Monica; Tu Dongsheng; Shepherd Lois E; Pritchard Kathleen I; Livingston Robert B; Davidson Nancy E; Norton Larry; Perez Edith A; Abrams Jeffrey S; Cameron David A; Palmer Michael J; Pater Joseph L;
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2006-11.
-
2007: Pledgie-Tracy Allison; Sobolewski Michele D; Davidson Nancy E
Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.
Molecular cancer therapeutics 2007;6(3):1013-21.
-
2007: Stebbing Justin; Stearns Vered; Davidson Nancy E
Role of CYP2D6 testing in selection of endocrine therapy for breast cancer.
Pharmacogenomics 2007;8(1):1-3.
-
2007: Zhou Qun; Atadja Peter; Davidson Nancy E
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.
Cancer biology & therapy 2007;6(1):64-9.
-
2007: Bao Ting; Davidson Nancy E
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Breast cancer research : BCR 2007;9(6):115.
-
2006: Visvanathan Kala; Santor Deborah; Ali Syed Z; Hong In Soon; Davidson Nancy E; Helzlsouer Kathy J
The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavage.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(12):2553-6.
-
2006: Brown Regina J; Davidson Nancy E
Adjuvant hormonal therapy for premenopausal women with breast cancer.
Seminars in oncology 2006;33(6):657-63.
-
2006: Visvanathan Kala; Sukumar Saraswati; Davidson Nancy E
Epigenetic biomarkers and breast cancer: cause for optimism.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6591-3.
-
2006: Carlson Robert W; O'Neill Anne M; Goldstein Lori J; Sikic Branimir I; Abramson Neil; Stewart James A; Davidson Nancy E; Wood William C;
A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology Group.
Cancer investigation 2006;24(7):677-81.
-
2006: Wolff Antonio C; Davidson Nancy E
Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):4949-51.
-
2006: Khatcheressian James L; Wolff Antonio C; Smith Thomas J; Grunfeld Eva; Muss Hyman B; Vogel Victor G; Halberg Francine; Somerfield Mark R; Davidson Nancy E;
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5091-7.
-
2006: Ingle James N; Tu Dongsheng; Pater Joseph L; Martino Silvana; Robert Nicholas J; Muss Hyman B; Piccart Martine J; Castiglione Monica; Shepherd Lois E; Pritchard Kathleen I; Livingston Robert B; Davidson Nancy E; Norton Larry; Perez Edith A; Abrams Jeffrey S; Cameron David A; Palmer Michael J; Goss Paul E
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.
Breast cancer research and treatment 2006;99(3):295-300.
-
2006: Abukhdeir Abde M; Blair Brian G; Brenner Keith; Karakas Bedri; Konishi Hiroyuki; Lim Joselin; Sahasranaman Vanita; Huang Yi; Keen Judith; Davidson Nancy; Vitolo Michele I; Bachman Kurtis E; Park Ben Ho
Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.
Breast cancer research and treatment 2006;99(1):23-33.
-
2006: Zhou Qun; Davidson Nancy E
Silencing estrogen receptor alpha in breast cancer cells.
Cancer biology & therapy 2006;5(7):848-9.
-
2006: Perez Edith A; Suman Vera J; Davidson Nancy E; Martino Silvana; Kaufman Peter A; Lingle Wilma L; Flynn Patrick J; Ingle James N; Visscher Daniel; Jenkins Robert B
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3032-8.
-
2006: Huang Yi; Keen Judith C; Pledgie Allison; Marton Laurence J; Zhu Tao; Sukumar Saraswati; Park Ben Ho; Blair Brian; Brenner Keith; Casero Robert A; Davidson Nancy E
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.
The Journal of biological chemistry 2006;281(28):19055-63.
-
2006: Sharma Dipali; Saxena Neeraj K; Davidson Nancy E; Vertino Paula M
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
Cancer research 2006;66(12):6370-8.
-
2006: Fackler Mary Jo; Malone Kara; Zhang Zhe; Schilling Eric; Garrett-Mayer Elizabeth; Swift-Scanlan Theresa; Lange Julie; Nayar Ritu; Davidson Nancy E; Khan Seema A; Sukumar Saraswati
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3306-10.
-
2006: Wolff Antonio C; Jones Richard J; Davidson Nancy E; Jeter Stacie C; Stearns Vered
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2392-4; author reply 2394-5.
-
2006: Kominsky Scott L; Davidson Nancy E
A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2227-9.
-
2006: Modzelewska Aneta; Pettit Catherine; Achanta Geetha; Davidson Nancy E; Huang Peng; Khan Saeed R
Anticancer activities of novel chalcone and bis-chalcone derivatives.
Bioorganic & medicinal chemistry 2006;14(10):3491-5.
-
2006: Zucker Stanley; Wang Molin; Sparano Joseph A; Gradishar William J; Ingle James N; Davidson Nancy E;
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.
Clinical breast cancer 2006;6(6):525-9.
-
2006: Yager James D; Davidson Nancy E
Estrogen carcinogenesis in breast cancer.
The New England journal of medicine 2006;354(3):270-82.
-
2005: Li Jinong; Orlandi Rosaria; White C Nicole; Rosenzweig Jason; Zhao Jing; Seregni Ettore; Morelli Daniele; Yu Yinhua; Meng Xiao-Ying; Zhang Zhen; Davidson Nancy E; Fung Eric T; Chan Daniel W
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Clinical chemistry 2005;51(12):2229-35.
-
2005: Pledgie Allison; Huang Yi; Hacker Amy; Zhang Zhe; Woster Patrick M; Davidson Nancy E; Casero Robert A
Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines.
The Journal of biological chemistry 2005;280(48):39843-51.
-
2005: Davidson Nancy E; Morrow Monica; Kopans Daniel B; Koerner Frederick C
Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node.
The New England journal of medicine 2005;353(20):2177-85.
-
2005: Wolff Antonio C; O'Neill Anne; Kennedy M John; Stewart James A; Gradishar William J; Lord Raymond S; Davidson Nancy E; Wood William C
Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193.
Clinical breast cancer 2005;6(4):334-9.
-
2005: Romond Edward H; Perez Edith A; Bryant John; Suman Vera J; Geyer Charles E; Davidson Nancy E; Tan-Chiu Elizabeth; Martino Silvana; Paik Soonmyung; Kaufman Peter A; Swain Sandra M; Pisansky Thomas M; Fehrenbacher Louis; Kutteh Leila A; Vogel Victor G; Visscher Daniel W; Yothers Greg; Jenkins Robert B; Brown Ann M; Dakhil Shaker R; Mamounas Eleftherios P; Lingle Wilma L; Klein Pamela M; Ingle James N; Wolmark Norman
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
The New England journal of medicine 2005;353(16):1673-84.
-
2005: Davidson Nancy E; Sukumar Saraswati
Of Snail, mice, and women.
Cancer cell 2005;8(3):173-4.
-
2005: Goss Paul E; Ingle James N; Martino Silvana; Robert Nicholas J; Muss Hyman B; Piccart Martine J; Castiglione Monica; Tu Dongsheng; Shepherd Lois E; Pritchard Kathleen I; Livingston Robert B; Davidson Nancy E; Norton Larry; Perez Edith A; Abrams Jeffrey S; Cameron David A; Palmer Michael J; Pater Joseph L
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
Journal of the National Cancer Institute 2005;97(17):1262-71.
-
2005: Huang Yi; Pledgie Allison; Rubin Ethel; Marton Laurence J; Woster Patrick M; Sukumar Saraswati; Casero Robert A; Davidson Nancy E
Role of p53/p21(Waf1/Cip1) in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells.
Cancer biology & therapy 2005;4(9):1006-13.
-
2005: Davidson Nancy E; O'Neill Anne M; Vukov Allen M; Osborne C Kent; Martino Silvana; White Douglas R; Abeloff Martin D
Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5973-82.
-
2005: Keen Judith C; Zhou Qun; Park Ben Ho; Pettit Catherine; Mack Kelly M; Blair Brian; Brenner Keith; Davidson Nancy E
Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability.
The Journal of biological chemistry 2005;280(33):29519-24.
-
2005: Sharma Dipali; Blum Julie; Yang Xiaowei; Beaulieu Normand; Macleod A Robert; Davidson Nancy E
Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 2005;19(7):1740-51.
-
2005: Mock Victoria; Frangakis Constantine; Davidson Nancy E; Ropka Mary E; Pickett Mary; Poniatowski Barbara; Stewart Kerry J; Cameron Lane; Zawacki Kristin; Podewils Laura J; Cohen Gary; McCorkle Ruth
Exercise manages fatigue during breast cancer treatment: a randomized controlled trial.
Psycho-oncology 2005;14(6):464-77.
-
2005: Agoston Agoston T; Argani Pedram; Yegnasubramanian Srinivasan; De Marzo Angelo M; Ansari-Lari Mohammad Ali; Hicks Jessica L; Davidson Nancy E; Nelson William G
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer.
The Journal of biological chemistry 2005;280(18):18302-10.
-
2005: Huang Yi; Pledgie Allison; Casero Robert A; Davidson Nancy E
Molecular mechanisms of polyamine analogs in cancer cells.
Anti-cancer drugs 2005;16(3):229-41.
-
2005: Davidson Nancy E; Morrow Monica
Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer.
Journal of the National Cancer Institute 2005;97(3):159-61.
-
2005: Davis-Sproul J M; Harris M P; Davidson N E; Kobrin B J; Jaffee E M; Emens L A
Cost-effective manufacture of an allogeneic GM-CSF-secreting breast tumor vaccine in an academic cGMP facility.
Cytotherapy 2005;7(1):46-56.
-
2004: Keen Judith C; Garrett-Mayer Elizabeth; Pettit Catherine; Mack Kelly M; Manning Jasper; Herman James G; Davidson Nancy E
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.
Cancer biology & therapy 2004;3(12):1304-12.
-
2004: Sparano Joseph A; Bernardo Patricia; Stephenson Patricia; Gradishar William J; Ingle James N; Zucker Stanley; Davidson Nancy E
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4683-90.
-
2004: Jacobs Michael A; Ouwerkerk Ronald; Wolff Antonio C; Stearns Vered; Bottomley Paul A; Barker Peter B; Argani Pedram; Khouri Nagi; Davidson Nancy E; Bhujwalla Zaver M; Bluemke David A
Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications.
Technology in cancer research & treatment 2004;3(6):543-50.
-
2004: Perez Edith A; Suman Vera J; Davidson Nancy E; Kaufman Peter A; Martino Silvana; Dakhil Shaker R; Ingle James N; Rodeheffer Richard J; Gersh Bernard J; Jaffe Allan S
Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3700-4.
-
2004: Emens Leisha A; Davidson Nancy E
Trastuzumab in breast cancer.
Oncology (Williston Park, N.Y.) 2004;18(9):1117-28; discussion 1131-2, 1137-8.
-
2004: Gabrielson Edward; Tully Ellen; Hacker Amy; Pegg Anthony E; Davidson Nancy E; Casero Robert A
Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine.
Cancer chemotherapy and pharmacology 2004;54(2):122-6.
-
2004: Park Ben Ho; Davidson Nancy E
Estrogen receptor status, cell cycling and paclitaxel: looking for a "hormone"-ious explanation.
Cancer biology & therapy 2004;3(5):468-9.
-
2004: Stearns Vered; Davidson Nancy E
Déjà vu for breast cancer two?
Journal of the National Cancer Institute 2004;96(7):497-9.
-
2004: Emens Leisha A; Armstrong Deborah; Biedrzycki Barbara; Davidson Nancy; Davis-Sproul Janice; Fetting John; Jaffee Elizabeth; Onners Beth; Piantadosi Steve; Reilly Richard T; Stearns Vered; Tartakovsky Irena; Visvanathan Kala; Wolff Antonio
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin.
Human gene therapy 2004;15(3):313-37.
-
2004: Huang Yi; Keen Judith C; Hager Erin; Smith Renee; Hacker Amy; Frydman Benjamin; Valasinas Aldonia L; Reddy Venodhar K; Marton Laurence J; Casero Robert A; Davidson Nancy E
Regulation of polyamine analogue cytotoxicity by c-Jun in human MDA-MB-435 cancer cells.
Molecular cancer research : MCR 2004;2(2):81-8.
-
2004: Prowell Tatiana M; Davidson Nancy E
What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?
The oncologist 2004;9(5):507-17.
-
2004: Stearns V; Davidson N E; Flockhart D A
Pharmacogenetics in the treatment of breast cancer.
The pharmacogenomics journal 2004;4(3):143-53.
-
2003: Wolff Antonio C; Armstrong Deborah K; Fetting John H; Carducci M Katherine; Riley Carol D; Bender John F; Casero Robert A; Davidson Nancy E
A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5922-8.
-
2003: Davidson Nancy E; Visvanathan Kala; Emens Leisha
New findings about endocrine therapy for breast cancer.
Breast (Edinburgh, Scotland) 2003;12(6):368-72.
-
2003: Zhu Kangmin; Davidson Nancy E; Hunter Sandra; Yang Xiaowei; Payne-Wilks Kathleen; Roland Chanel L; Phillips Dawn; Bentley Christy; Dai Min; Williams Scott M
Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes.
Cancer causes & control : CCC 2003;14(9):827-36.
-
2003: Goss Paul E; Ingle James N; Martino Silvana; Robert Nicholas J; Muss Hyman B; Piccart Martine J; Castiglione Monica; Tu Dongsheng; Shepherd Lois E; Pritchard Kathleen I; Livingston Robert B; Davidson Nancy E; Norton Larry; Perez Edith A; Abrams Jeffrey S; Therasse Patrick; Palmer Michael J; Pater Joseph L
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
The New England journal of medicine 2003;349(19):1793-802.
-
2003: Keen Judith Clancy; Yan Lan; Mack Kelly M; Pettit Catherine; Smith Dawn; Sharma Dipali; Davidson Nancy E
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Breast cancer research and treatment 2003;81(3):177-86.
-
2003: Yan Lan; Nass Sharyl J; Smith Dawn; Nelson William G; Herman James G; Davidson Nancy E
Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
Cancer biology & therapy 2003;2(5):552-6.
-
2003: Huang Yi; Hager Erin R; Phillips Dawn L; Dunn Valerie R; Hacker Amy; Frydman Benjamin; Kink John A; Valasinas Aldonia L; Reddy Venodhar K; Marton Laurence J; Casero Robert A; Davidson Nancy E
A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2769-77.
-
2003: Kumar Srinivas K; Hager Erin; Pettit Catherine; Gurulingappa Hallur; Davidson Nancy E; Khan Saeed R
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
Journal of medicinal chemistry 2003;46(14):2813-5.
-
2003: Emens Leisha A; Davidson Nancy E
The follow-up of breast cancer.
Seminars in oncology 2003;30(3):338-48.
-
2003: Citron Marc L; Berry Donald A; Cirrincione Constance; Hudis Clifford; Winer Eric P; Gradishar William J; Davidson Nancy E; Martino Silvana; Livingston Robert; Ingle James N; Perez Edith A; Carpenter John; Hurd David; Holland James F; Smith Barbara L; Sartor Carolyn I; Leung Eleanor H; Abrams Jeffrey; Schilsky Richard L; Muss Hyman B; Norton Larry
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1431-9.
-
2003: Visvanathan Kala; Davidson Nancy E
Aromatase inhibitors as adjuvant therapy in breast cancer.
Oncology (Williston Park, N.Y.) 2003;17(3):335-42, 347; discussion 347-50, 354.
-
2003: Keen Judith Clancy; Davidson Nancy E
The biology of breast carcinoma.
Cancer 2003;97(3 Suppl):825-33.
-
2003: Emens Leisha A; Davidson Nancy E
Adjuvant hormonal therapy for premenopausal women with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):486S-94S.
-
2003: Come Steven E; Buzdar Aman U; Arteaga Carlos L; Brodie Angela M; Davidson Nancy E; Dowsett Mitch; Ingle James N; Johnston Stephen R D; Lee Adrian V; Osborne C Kent; Pritchard Kathleen I; Vogel Victor G; Winer Eric P; Hart Carol S
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):443S-6S.
-
2003: Yang Xiaowei; Groshen Susan; Formenti Silvia C; Davidson Nancy E; Press Michael F
P7 antigen expression in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):201-6.
-
2002: Emens Leisha A; Kennedy M John; Fetting John H; Davidson Nancy E; Garrett Elizabeth; Armstrong Deborah K
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer.
Breast cancer research and treatment 2002;76(2):145-56.
-
2002: Davidson Nancy E
Ongoing US cooperative group trials using taxanes in the adjuvant setting.
Clinical breast cancer 2002;3 Suppl 2():S53-8.
-
2002: Davidson Nancy E; Helzlsouer Kathy J
Good news about oral contraceptives.
The New England journal of medicine 2002;346(26):2078-9.
-
2002: Roche Patrick C; Suman Vera J; Jenkins Robert B; Davidson Nancy E; Martino Silvana; Kaufman Peter A; Addo Ferdinand K; Murphy Bronagh; Ingle James N; Perez Edith A
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.
Journal of the National Cancer Institute 2002;94(11):855-7.
-
2002: Davidson Nancy E; Levine Mark
Breast cancer consensus meetings: vive la difference?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1719-20.
-
2002: Wolff Antonio C; Davidson Nancy E
Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease.
The oncologist 2002;7(3):239-45.
-
2001: Wolff A C; Davidson N E
Use of SERMs for the adjuvant therapy of early-stage breast cancer.
Annals of the New York Academy of Sciences 2001;949():80-8.
-
2001: Yang X; Phillips D L; Ferguson A T; Nelson W G; Herman J G; Davidson N E
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Cancer research 2001;61(19):7025-9.
-
2001: Dees E C; Davidson N E
Ovarian ablation as adjuvant therapy for breast cancer.
Seminars in oncology 2001;28(4):322-31.
-
2001: Yang X; Yan L; Davidson N E
DNA methylation in breast cancer.
Endocrine-related cancer 2001;8(2):115-27.
-
2001: Armstrong D K; Davidson N E
Dose intensity for breast cancer.
Oncology (Williston Park, N.Y.) 2001;15(6):701-8, 712; discussion 712-4, 717-8.
-
2001: Yan L; Yang X; Davidson N E
Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer.
Journal of mammary gland biology and neoplasia 2001;6(2):183-92.
-
2001: Evron E; Dooley W C; Umbricht C B; Rosenthal D; Sacchi N; Gabrielson E; Soito A B; Hung D T; Ljung B; Davidson N E; Sukumar S
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.
Lancet 2001;357(9265):1335-6.
-
2001: Hahm H A; Dunn V R; Butash K A; Deveraux W L; Woster P M; Casero R A; Davidson N E
Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(2):391-9.
-
2001: Armstrong D K; Davidson N E
Dose intensity for breast cancer: where do we go from here?
Breast disease 2001;14():91-7.
-
2001: Davidson N E
Ovarian ablation as adjuvant therapy for breast cancer.
Journal of the National Cancer Institute. Monographs 2001;(30):67-71.
-
2001: Kensler T W; Davidson N E; Groopman J D; Muñoz A
Biomarkers and surrogacy: relevance to chemoprevention.
IARC scientific publications 2001;154():27-47.
-
2000: Yang X; Ferguson A T; Nass S J; Phillips D L; Butash K A; Wang S M; Herman J G; Davidson N E
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
Cancer research 2000;60(24):6890-4.
-
2000: van der Wall E; Horn T; Bright E; Passos-Coehlo J L; Bond S; Clarke B; Altomonte V; McIntyre K; Vogelsang G; Noga S J; Davis J M; Thomassen J; Ohly K V; Lee S M; Fetting J; Armstrong D K; Davidson N E; Hess A D; Kennedy M J
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
British journal of cancer 2000;83(11):1405-11.
-
2000: Wolff A C; Davidson N E
Early operable breast cancer.
Current treatment options in oncology 2000;1(3):210-20.
-
2000: Nass S J; Herman J G; Gabrielson E; Iversen P W; Parl F F; Davidson N E; Graff J R
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
Cancer research 2000;60(16):4346-8.
-
2000: Jackisch C; Hahm H A; Tombal B; McCloskey D; Butash K; Davidson N E; Denmeade S R
Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2844-50.
-
2000: Davidson N E
Combined endocrine therapy for breast cancer--new life for an old idea?
Journal of the National Cancer Institute 2000;92(11):859-60.
-
2000: Wolff A C; Davidson N E
Primary systemic therapy in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1558-69.
-
2000: McCloskey D E; Woster P M; Casero R A; Davidson N E
Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethylN-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):17-23.
-
2000: Hahm H A; Armstrong D K; Chen T L; Grochow L; Passos-Coelho J; Goodman S N; Davidson N E; Kennedy M J
Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):335-43.
-
1999: Nass S J; Ferguson A T; El-Ashry D; Nelson W G; Davidson N E
Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells.
Oncogene 1999;18(52):7453-61.
-
1999: Wolff A C; Davidson N E
New data on adjuvant therapy for breast cancer.
Current oncology reports 1999;1(1):31-7.
-
1999: Recht A; Gray R; Davidson N E; Fowble B L; Solin L J; Cummings F J; Falkson G; Falkson H C; Taylor S G; Tormey D C
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1689-700.
-
1999: Kottke T J; Blajeski A L; Martins L M; Mesner P W; Davidson N E; Earnshaw W C; Armstrong D K; Kaufmann S H
Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis.
The Journal of biological chemistry 1999;274(22):15927-36.
-
1999: Nass S J; Davidson N E
The biology of breast cancer.
Hematology/oncology clinics of North America 1999;13(2):311-32.
-
1999: Davidson N E; Hahm H A; McCloskey D E; Woster P M; Casero R A
Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment.
Endocrine-related cancer 1999;6(1):69-73.
-
1999: Smith T J; Davidson N E; Schapira D V; Grunfeld E; Muss H B; Vogel V G; Somerfield M R
American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1080-2.
-
1999: Mikhak B; Zahurak M; Abeloff M D; Fetting J H; Davidson N E; Donehower R C; Waterfield W; Kennedy M J
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
Cancer 1999;85(4):899-904.
-
1999: Subramanyan S; Abeloff M D; Bond S E; Davidson N E; Fetting J H; Gordon G B; Kennedy M J
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
Cancer chemotherapy and pharmacology 1999;43(6):497-502.
-
1998: Davidson N E
Environmental estrogens and breast cancer risk.
Current opinion in oncology 1998;10(5):475-8.
-
1998: Ferguson A T; Lapidus R G; Davidson N E
Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression.
Oncogene 1998;17(5):577-83.
-
1998: Nass S J; Hahm H A; Davidson N E
Breast cancer biology blossoms in the clinic.
Nature medicine 1998;4(7):761-2.
-
1998: Lapidus R G; Nass S J; Butash K A; Parl F F; Weitzman S A; Graff J G; Herman J G; Davidson N E
Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
Cancer research 1998;58(12):2515-9.
-
1998: Hahm H A; Davidson N E; Giguere J K; DiBernardo C; O'Reilly S
Breast cancer metastatic to the choroid.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2280-2.
-
1998: Kensler T W; He X; Otieno M; Egner P A; Jacobson L P; Chen B; Wang J S; Zhu Y R; Zhang B C; Wang J B; Wu Y; Zhang Q N; Qian G S; Kuang S Y; Fang X; Li Y F; Yu L Y; Prochaska H J; Davidson N E; Gordon G B; Gorman M B; Zarba A; Enger C; Muñoz A; Helzlsouer K J
Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(2):127-34.
-
1998: Lapidus R G; Nass S J; Davidson N E
The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Journal of mammary gland biology and neoplasia 1998;3(1):85-94.
-
1998: Ferguson A T; Lapidus R G; Davidson N E
The regulation of estrogen receptor expression and function in human breast cancer.
Cancer treatment and research 1998;94():255-78.
-
1997: Ferguson A T; Vertino P M; Spitzner J R; Baylin S B; Muller M T; Davidson N E
Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells.
The Journal of biological chemistry 1997;272(51):32260-6.
-
1997: Davidson N E; Yager J D
Pesticides and breast cancer: fact or fad?
Journal of the National Cancer Institute 1997;89(23):1743-4.
-
1997: Jacobson L P; Zhang B C; Zhu Y R; Wang J B; Wu Y; Zhang Q N; Yu L Y; Qian G S; Kuang S Y; Li Y F; Fang X; Zarba A; Chen B; Enger C; Davidson N E; Gorman M B; Gordon G B; Prochaska H J; Egner P A; Groopman J D; Muñoz A; Helzlsouer K J; Kensler T W
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(4):257-65.
-
1997: Zhang B C; Zhu Y R; Wang J B; Wu Y; Zhang Q N; Qian G S; Kuang S Y; Li Y F; Fang X; Yu L Y; De Flora S; Jacobson L P; Zarba A; Egner P A; He X; Wang J S; Chen B; Enger C L; Davidson N E; Gordon G B; Gorman M B; Prochaska H J; Groopman J D; Muñoz A; Kensler T W
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
Journal of cellular biochemistry. Supplement 1997;28-29():166-73.
-
1997: Ferguson A T; Davidson N E
Regulation of estrogen receptor alpha function in breast cancer.
Critical reviews in oncogenesis 1997;8(1):29-46.
-
1997: Denmeade S R; McCloskey D E; Joseph I B; Hahm H A; Isaacs J T; Davidson N E
Apoptosis in hormone-responsive malignancies.
Advances in pharmacology (San Diego, Calif.) 1997;41():553-83.
-
1996: Ross A A; Layton T J; Ostrander A B; Passos-Coelho J L; Davis J M; Huelskamp A M; Noga S J; Davidson N E; Kennedy M J; Cooper B W; Gerson S L; Lazarus H M; Holland K; Gluck S; Moss T J; Kaubish A; Vahdat L; Antman K
Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts.
Journal of hematotherapy 1996;5(5):549-52.
-
1996: Passos-Coelho J L; Ross A A; Kahn D J; Moss T J; Davis J M; Huelskamp A M; Noga S J; Davidson N E; Kennedy M J
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2569-75.
-
1996: Davidson N E
Is hormone replacement therapy a risk?
Scientific American 1996;275(3):101.
-
1996: Pizer E S; Jackisch C; Wood F D; Pasternack G R; Davidson N E; Kuhajda F P
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Cancer research 1996;56(12):2745-7.
-
1996: McCloskey D E; Kaufmann S H; Prestigiacomo L J; Davidson N E
Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):847-54.
-
1996: Lapidus R G; Ferguson A T; Ottaviano Y L; Parl F F; Smith H S; Weitzman S A; Baylin S B; Issa J P; Davidson N E
Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):805-10.
-
1996: McCloskey D E; Yang J; Woster P M; Davidson N E; Casero R A
Polyamine analogue induction of programmed cell death in human lung tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):441-6.
-
1996: Issa J P; Zehnbauer B A; Civin C I; Collector M I; Sharkis S J; Davidson N E; Kaufmann S H; Baylin S B
The estrogen receptor CpG island is methylated in most hematopoietic neoplasms.
Cancer research 1996;56(5):973-77.
-
1996: McCloskey D E; Armstrong D K; Jackisch C; Davidson N E
Programmed cell death in human breast cancer cells.
Recent progress in hormone research 1996;51():493-508.
-
1995: Graff J R; Herman J G; Lapidus R G; Chopra H; Xu R; Jarrard D F; Isaacs W B; Pitha P M; Davidson N E; Baylin S B
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Cancer research 1995;55(22):5195-9.
-
1995: Herman J G; Merlo A; Mao L; Lapidus R G; Issa J P; Davidson N E; Sidransky D; Baylin S B
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
Cancer research 1995;55(20):4525-30.
-
1995: McCloskey D E; Casero R A; Woster P M; Davidson N E
Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue.
Cancer research 1995;55(15):3233-6.
-
1995: Elledge R M; Gray R; Mansour E; Yu Y; Clark G M; Ravdin P; Osborne C K; Gilchrist K; Davidson N E; Robert N
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.
Journal of the National Cancer Institute 1995;87(16):1254-6.
-
1995: Ferguson A T; Lapidus R G; Baylin S B; Davidson N E
Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
Cancer research 1995;55(11):2279-83.
-
1995: Kennedy M J; Armstrong D K; Huelskamp A M; Ohly K; Clarke B V; Colvin O M; Grochow L B; Chen T L; Davidson N E
Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1136-43.
-
1995: Passos-Coelho J L; Braine H G; Davis J M; Huelskamp A M; Schepers K G; Ohly K; Clarke B; Wright S K; Noga S J; Davidson N E
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):705-14.
-
1995: Passos-Coelho J L; Ross A A; Moss T J; Davis J M; Huelskamp A M; Noga S J; Davidson N E; Kennedy M J
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.
Blood 1995;85(4):1138-43.
-
1994: May W S; Tyler P G; Ito T; Armstrong D K; Qatsha K A; Davidson N E
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis.
The Journal of biological chemistry 1994;269(43):26865-70.
-
1994: Armstrong D K; Kaufmann S H; Ottaviano Y L; Furuya Y; Buckley J A; Isaacs J T; Davidson N E
Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells.
Cancer research 1994;54(20):5280-3.
-
1994: Cobleigh M A; Berris R F; Bush T; Davidson N E; Robert N J; Sparano J A; Tormey D C; Wood W C
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.
JAMA : the journal of the American Medical Association 1994;272(7):540-5.
-
1994: Issa J P; Ottaviano Y L; Celano P; Hamilton S R; Davidson N E; Baylin S B
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.
Nature genetics 1994;7(4):536-40.
-
1994: Ottaviano Y L; Issa J P; Parl F F; Smith H S; Baylin S B; Davidson N E
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.
Cancer research 1994;54(10):2552-5.
-
1994: Passos-Coelho J; Ross A A; Davis J M; Huelskamp A M; Clarke B; Noga S J; Davidson N E; Kennedy M J
Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
Cancer research 1994;54(9):2366-71.
-
1994: Kennedy M J; Vogelsang G B; Jones R J; Farmer E R; Hess A D; Altomonte V; Huelskamp A M; Davidson N E
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):249-57.
-
1994: Davidson N E; Abeloff M D
Adjuvant therapy of breast cancer.
World journal of surgery 1994;18(1):112-6.
-
1994: Davidson N E
Ovarian ablation as treatment for young women with breast cancer.
Journal of the National Cancer Institute. Monographs 1994;(16):95-9.
-
1993: Armstrong D K; Fetting J H; Davidson N E; Gordon G B; Huelskamp A M; Abeloff M D
Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer.
Breast cancer research and treatment 1993;28(3):277-84.
-
1993: Ross A A; Cooper B W; Lazarus H M; Mackay W; Moss T J; Ciobanu N; Tallman M S; Kennedy M J; Davidson N E; Sweet D
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.
Blood 1993;82(9):2605-10.
-
1993: Kennedy M J; Davis J; Passos-Coelho J; Noga S J; Huelskamp A M; Ohly K; Davidson N E
Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer.
Cancer research 1993;53(22):5424-8.
-
1993: Kaufmann S H; Desnoyers S; Ottaviano Y; Davidson N E; Poirier G G
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
Cancer research 1993;53(17):3976-85.
-
1993: Davidson N E; Mank A R; Prestigiacomo L J; Bergeron R J; Casero R A
Growth inhibition of hormone-responsive and -resistant human breast cancer cells in culture by N1, N12-bis(ethyl)spermine.
Cancer research 1993;53(9):2071-5.
-
1993: Davidson N E; Abeloff M D
Menstrual effects on surgical treatment for breast cancer.
Cancer treatment reviews 1993;19(2):105-12.
-
1993: Kennedy M J; Vogelsang G B; Beveridge R A; Farmer E R; Altomonte V; Huelskamp A M; Davidson N E
Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):478-84.
-
1993: Davidson N E; Prestigiacomo L J; Hahm H A
Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells.
Cancer research 1993;53(2):291-7.
-
1993: Kensler T W; Davidson N E; Groopman J D; Roebuck B D; Prochaska H J; Talalay P
Chemoprotection by inducers of electrophile detoxication enzymes.
Basic life sciences 1993;61():127-36.
-
1993: Kronthal A J; Fishman E K; Gottlieb L M; Davidson N E
CT evaluation of breast cancer: spectrum of disease.
Critical reviews in diagnostic imaging 1993;34(3-4):159-237.
-
1992: Davidson N E
Biology of breast cancer and its clinical implications.
Current opinion in oncology 1992;4(6):1003-9.
-
1992: Armstrong D K; Isaacs J T; Ottaviano Y L; Davidson N E
Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468.
Cancer research 1992;52(12):3418-24.
-
1992: Sidransky D; Tokino T; Helzlsouer K; Zehnbauer B; Rausch G; Shelton B; Prestigiacomo L; Vogelstein B; Davidson N
Inherited p53 gene mutations in breast cancer.
Cancer research 1992;52(10):2984-6.
-
1992: Davidson N E
Out of the courtroom and into the clinic.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):517-9.
-
1992: Kennedy M J; Prestigiacomo L J; Tyler G; May W S; Davidson N E
Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Cancer research 1992;52(5):1278-83.
-
1992: Davidson N E
Tamoxifen--panacea or Pandora's box?
The New England journal of medicine 1992;326(13):885-6.
-
1992: Armstrong D K; Gordon G B; Hilton J; Streeper R T; Colvin O M; Davidson N E
Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
Cancer research 1992;52(6):1416-21.
-
1992: Davidson N E; Abeloff M D
Adjuvant systemic therapy in women with early-stage breast cancer at high risk for relapse.
Journal of the National Cancer Institute 1992;84(5):301-5.
-
1992: Davidson N E; Abeloff M D
Adjuvant chemotherapy of axillary lymph-node-positive breast cancer.
Cancer treatment and research 1992;60():115-45.
-
1991: Davidson N E
Biology of breast cancer.
Current opinion in oncology 1991;3(6):988-94.
-
1991: Kennedy M J; Beveridge R A; Rowley S D; Gordon G B; Abeloff M D; Davidson N E
High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.
Journal of the National Cancer Institute 1991;83(13):920-6.
-
1991: Rowley S D; Piantadosi S; Marcellus D C; Jones R J; Davidson N E; Davis J M; Kennedy J; Wiley J M; Wingard J R; Yeager A M
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Bone marrow transplantation 1991;7(3):183-91.
-
1991: Kyprianou N; English H F; Davidson N E; Isaacs J T
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
Cancer research 1991;51(1):162-6.
-
1990: Davidson N E
Biology and prognostic factors of breast cancer.
Current opinion in oncology 1990;2(6):1025-30.
-
1990: Falco J P; Baylin S B; Lupu R; Borges M; Nelkin B D; Jasti R K; Davidson N E; Mabry M
v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.
The Journal of clinical investigation 1990;85(6):1740-5.
-
1990: Davidson N E; Egner P A; Kensler T W
Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
Cancer research 1990;50(8):2251-5.
-
1990: Abeloff M D; Beveridge R A; Donehower R C; Fetting J H; Davidson N E; Gordon G G; Waterfield W C; Damron D J
Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancer.
Journal of the National Cancer Institute 1990;82(7):570-4.
-
1989: Davidson N E
Biology of breast cancer and its clinical implications.
Current opinion in oncology 1989;1(2):269-76.
-
1989: Nigro J M; Baker S J; Preisinger A C; Jessup J M; Hostetter R; Cleary K; Bigner S H; Davidson N; Baylin S; Devilee P
Mutations in the p53 gene occur in diverse human tumour types.
Nature 1989;342(6250):705-8.
-
1989: Geller R B; Boone L B; Karp J E; Davidson N; Selonick S E; Edwards J; Burke P J
Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy.
Cancer 1989;64(3):629-34.
-
1989: Davidson N E; Lippman M E
The role of estrogens in growth regulation of breast cancer.
Critical reviews in oncogenesis 1989;1(1):89-111.
-
1988: Bates S E; Davidson N E; Valverius E M; Freter C E; Dickson R B; Tam J P; Kudlow J E; Lippman M E; Salomon D S
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.
Molecular endocrinology (Baltimore, Md.) 1988;2(6):543-55.
-
1987: Davidson N E; Lippman M E
Stimulation of breast cancer with estrogens: how much clinical value?
European journal of cancer & clinical oncology 1987;23(7):897-900.
-
1987: Davidson N E; Gelmann E P; Lippman M E; Dickson R B
Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.
Molecular endocrinology (Baltimore, Md.) 1987;1(3):216-23.
-
1986: Kensler T W; Egner P A; Davidson N E; Roebuck B D; Pikul A; Groopman J D
Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Cancer research 1986;46(8):3924-31.
-
1986: Davidson N E; Bronzert D A; Chambon P; Gelmann E P; Lippman M E
Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products.
Cancer research 1986;46(4 Pt 2):1904-8.
-
1986: Kasid A; Davidson N E; Gelmann E P; Lippman M E
Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells.
The Journal of biological chemistry 1986;261(12):5562-7.
-
1985: Davidson N E; Lippman M E
Combined therapy in advanced breast cancer.
European journal of cancer & clinical oncology 1985;21(10):1123-6.
-
1976: Kensler T W; Busby W F; Davidson N E; Wogan G N
Effect of hepatocarcinogens on the binding of glucocorticoid-receptor complex in rat liver nuclei.
Cancer research 1976;36(12):4647-51.
-
1976: Kensler T W; Busby W F; Davidson N E; Wogan G N
Aflatoxin inhibition of glucocorticoid finding capacity of rat liver nuclei.
Biochimica et biophysica acta 1976;437(1):200-10.
Sign-in to see more